Type 2 Diabetes Mellitus study: CGM
Official title CGM for Management of Type 2 Diabetes in Pregnancy
ClinicalTrials.gov ID: NCT06628453
What this study is testing
- What it's testing
- The study wants to see if continuous glucose monitoring improves baby health and mom’s diabetes control compared with regular finger‑stick testing, and to learn what other factors affect pregnancy outcomes.
- Who it's for
- Pregnant individuals who have type 2 diabetes.
- What's involved
- You will wear a continuous glucose monitor or do finger‑stick checks from enrollment until delivery, give blood samples at enrollment, 24 weeks, 34 weeks and delivery, fill out surveys about stress and support, and have cord blood taken at birth.
- Time commitment
- The study runs from enrollment until delivery, with clinic visits for blood draws and surveys at enrollment, 24 weeks, 34 weeks, and at delivery.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Type 2 diabetes mellitus treated with daily insulin injections or oral hypoglycemic agents diagnosed before pregnancy or at less than 14 weeks...
- Pregnant with viable fetus at 6 to less than 23 weeks gestation
- Maternal age 18-50 years old
You likely can't join if
- Unable or unwilling to wear CGM due to intolerance to medical-grade adhesives or skin conditions
- Multiple gestation
- Major fetal anomaly or two or more minor fetal anomalies
- Planned delivery outside study consortium
- Participating in another conflicting treatment study
- Participation in this trial in a previous pregnancy
See the full eligibility criteria
- Type 2 diabetes mellitus treated with daily insulin injections or oral hypoglycemic agents diagnosed before pregnancy or at less than 14 weeks gestation with hemoglobin A1c 6.5% or greater
- Pregnant with viable fetus at 6 to less than 23 weeks gestation
- Maternal age 18-50 years old
- Unable or unwilling to wear CGM due to intolerance to medical-grade adhesives or skin conditions
- Multiple gestation
- Major fetal anomaly or two or more minor fetal anomalies
- Planned delivery outside study consortium
- Participating in another conflicting treatment study
- Participation in this trial in a previous pregnancy
- Patient unable to consent
- Physician refusal for other reasons
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- San Diego, California, United States
- Chapel Hill, North Carolina, United States
- Portland, Oregon, United States
- Philadelphia, Pennsylvania, United States
- Greenville, South Carolina, United States
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; San Diego, California, United States; Chapel Hill, North Carolina, United States; Portland, Oregon, United States; Philadelphia, Pennsylvania, United States; Greenville, South Carolina, United States and 1 more location. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.